LiveLive
SPX7,677.28-0.1900%IXIC26,151.30-0.5300%FTSE10,873.371.2100%GOLD4,615.80-0.1300%SILVER68.60-0.4200%PLATINUM1,873.000.2100%PALLADIUM1,360.00-0.0700%BRENT85.31-9.6200%DJI53,577.400.4400%WTI80.30-7.7600%NDX29,209.23-0.9600%NATGAS2.873.5000%BTC78,303.00-0.8800%RUT3,010.02-0.2600%VIX15.72-1.8100%ETH2,454.26-0.7800%DAX26,385.551.1300%BNB701.000.4900%XRP1.41-4.4400%CAC408,485.050.3800%NKY66,262.160.0700%DOGE0.09-4.2600%HSI25,652.970.6200%ADA0.21-3.8900%NIFTY24,207.75-0.1000%SOL97.04-1.6100%AAPL309.90-0.0400%SENSEX77,472.94-0.0800%MSFT491.712.0900%TASI11,263.550.2800%IBOV174,576.804.9500%GOOGL346.960.8000%TSLA350.253.9700%MERVAL3,009,028.804.0600%TSX36,957.631.6200%USD/PKR277.330.0300%ASX2009,127.800.8200%EUR/PKR323.830.0200%STI5,721.590.4800%GBP/PKR378.580.8700%SAR/PKR73.910.1200%FBMKLCI1,748.540.6800%AED/PKR75.560.0800%SET1,601.920.3700%KOSPI6,808.215.2100%USD/EUR0.860.1300%TWSE45,832.622.0000%GASOLINE2.91-13.1000%HEATOIL4.05-9.9500%COPPER6.793.2100%WHEAT715.504.9900%CORN527.258.9900%SOYBEANS1,240.501.2700%COFFEE327.30-8.7700%COCOA5,901.00-1.4900%SUGAR17.57-0.2300%COTTON88.541.6900%TRX0.34-2.0700%AVAX7.35-2.4500%LINK11.40-1.9700%DOT0.85-4.4600%LTC50.45-1.7800%SHIB0.00-3.7900%TON1.41-4.1800%XLM0.18-4.9000%HBAR0.08-2.9100%SUI0.75-5.9500%APT0.57-5.4500%UNI4.30-2.4600%PEPE0.00-6.2300%NEAR1.85-4.4400%ARB0.09-3.6000%OP0.10-2.6600%MATIC0.130.0000%INJ5.46-8.0200%FIL0.71-3.8300%ICP2.40-1.1700%STX0.000.0000%ETC7.69-4.4700%ALGO0.09-3.0700%VET0.01-2.5800%THETA0.18-4.5000%FTM0.030.3600%SAND0.04-3.1800%MANA0.07-1.9500%AXS0.94-3.2500%GALA0.00-4.7100%CRV0.32-3.1300%MKR1,575.79-0.8700%AMZN261.060.6200%NVDA213.05-3.0400%META570.054.8500%NFLX82.235.7300%AMD479.18-1.0800%AVGO356.74-6.1200%JPM356.69-1.8100%V384.145.4600%MA599.374.3600%XOM160.64-2.9700%CVX199.89-2.8400%KO91.643.1700%PEP142.271.5300%DIS111.257.0200%BA211.08-5.3700%BABA119.44-6.8000%JD29.361.8700%PDD87.750.5500%NIO4.45-1.7700%SPY765.91-0.2000%QQQ710.72-0.9500%DIA535.240.4400%IWM299.23-0.3300%GLD428.077.4100%SLV62.328.5000%TLT83.472.2200%HYG79.920.4900%LQD106.860.9600%XLF58.310.8100%XLK181.74-2.0900%XLE62.06-2.5400%XLV175.293.2800%SMH555.82-2.4500%ARKK86.379.1200%EEM67.252.9200%IBIT44.7222.1900%QAR/PKR76.230.5100%INR/PKR2.910.4000%JPY/PKR1.740.3900%CAD/PKR200.260.3700%AUD/PKR199.381.4800%NZD/PKR165.371.5400%MYR/PKR68.890.8300%THB/PKR8.481.2400%EUR/USD1.17-0.0300%GBP/USD1.360.1700%USD/JPY159.080.5100%USD/CHF0.800.8400%AUD/USD0.720.9300%USD/CAD1.390.4100%NZD/USD0.600.4900%USD/INR95.40-0.1000%USD/CNY6.71-0.3100%USD/HKD7.84-0.0200%USD/SGD1.27-0.0800%USD/KRW1,383.64-0.4100%USD/TRY48.110.3300%USD/ZAR15.94-0.9300%USD/MXN16.960.0300%USD/BRL5.16-0.2400%USD/RUB84.590.7100%USD/NGN1,345.44-0.3200%USD/EGP50.10-1.0300%USD/KES129.370.7200%USD/BDT123.262.1600%USD/LKR328.082.0300%USD/IDR17,690.00-0.6600%USD/THB32.75-0.3300%USD/MYR4.02-0.5700%USD/PHP61.630.0300%USD/VND26,109.00-0.2700%USD/ILS2.97-0.1600%USD/SAR3.753.0700%USD/AED3.670.0300%USD/QAR3.64-0.0400%USD/KWD0.31-0.3200%USD/BHD0.380.0300%USD/OMR0.390.4700%SPX7,677.28-0.1900%IXIC26,151.30-0.5300%FTSE10,873.371.2100%GOLD4,615.80-0.1300%SILVER68.60-0.4200%PLATINUM1,873.000.2100%PALLADIUM1,360.00-0.0700%BRENT85.31-9.6200%DJI53,577.400.4400%WTI80.30-7.7600%NDX29,209.23-0.9600%NATGAS2.873.5000%BTC78,303.00-0.8800%RUT3,010.02-0.2600%VIX15.72-1.8100%ETH2,454.26-0.7800%DAX26,385.551.1300%BNB701.000.4900%XRP1.41-4.4400%CAC408,485.050.3800%NKY66,262.160.0700%DOGE0.09-4.2600%HSI25,652.970.6200%ADA0.21-3.8900%NIFTY24,207.75-0.1000%SOL97.04-1.6100%AAPL309.90-0.0400%SENSEX77,472.94-0.0800%MSFT491.712.0900%TASI11,263.550.2800%IBOV174,576.804.9500%GOOGL346.960.8000%TSLA350.253.9700%MERVAL3,009,028.804.0600%TSX36,957.631.6200%USD/PKR277.330.0300%ASX2009,127.800.8200%EUR/PKR323.830.0200%STI5,721.590.4800%GBP/PKR378.580.8700%SAR/PKR73.910.1200%FBMKLCI1,748.540.6800%AED/PKR75.560.0800%SET1,601.920.3700%KOSPI6,808.215.2100%USD/EUR0.860.1300%TWSE45,832.622.0000%GASOLINE2.91-13.1000%HEATOIL4.05-9.9500%COPPER6.793.2100%WHEAT715.504.9900%CORN527.258.9900%SOYBEANS1,240.501.2700%COFFEE327.30-8.7700%COCOA5,901.00-1.4900%SUGAR17.57-0.2300%COTTON88.541.6900%TRX0.34-2.0700%AVAX7.35-2.4500%LINK11.40-1.9700%DOT0.85-4.4600%LTC50.45-1.7800%SHIB0.00-3.7900%TON1.41-4.1800%XLM0.18-4.9000%HBAR0.08-2.9100%SUI0.75-5.9500%APT0.57-5.4500%UNI4.30-2.4600%PEPE0.00-6.2300%NEAR1.85-4.4400%ARB0.09-3.6000%OP0.10-2.6600%MATIC0.130.0000%INJ5.46-8.0200%FIL0.71-3.8300%ICP2.40-1.1700%STX0.000.0000%ETC7.69-4.4700%ALGO0.09-3.0700%VET0.01-2.5800%THETA0.18-4.5000%FTM0.030.3600%SAND0.04-3.1800%MANA0.07-1.9500%AXS0.94-3.2500%GALA0.00-4.7100%CRV0.32-3.1300%MKR1,575.79-0.8700%AMZN261.060.6200%NVDA213.05-3.0400%META570.054.8500%NFLX82.235.7300%AMD479.18-1.0800%AVGO356.74-6.1200%JPM356.69-1.8100%V384.145.4600%MA599.374.3600%XOM160.64-2.9700%CVX199.89-2.8400%KO91.643.1700%PEP142.271.5300%DIS111.257.0200%BA211.08-5.3700%BABA119.44-6.8000%JD29.361.8700%PDD87.750.5500%NIO4.45-1.7700%SPY765.91-0.2000%QQQ710.72-0.9500%DIA535.240.4400%IWM299.23-0.3300%GLD428.077.4100%SLV62.328.5000%TLT83.472.2200%HYG79.920.4900%LQD106.860.9600%XLF58.310.8100%XLK181.74-2.0900%XLE62.06-2.5400%XLV175.293.2800%SMH555.82-2.4500%ARKK86.379.1200%EEM67.252.9200%IBIT44.7222.1900%QAR/PKR76.230.5100%INR/PKR2.910.4000%JPY/PKR1.740.3900%CAD/PKR200.260.3700%AUD/PKR199.381.4800%NZD/PKR165.371.5400%MYR/PKR68.890.8300%THB/PKR8.481.2400%EUR/USD1.17-0.0300%GBP/USD1.360.1700%USD/JPY159.080.5100%USD/CHF0.800.8400%AUD/USD0.720.9300%USD/CAD1.390.4100%NZD/USD0.600.4900%USD/INR95.40-0.1000%USD/CNY6.71-0.3100%USD/HKD7.84-0.0200%USD/SGD1.27-0.0800%USD/KRW1,383.64-0.4100%USD/TRY48.110.3300%USD/ZAR15.94-0.9300%USD/MXN16.960.0300%USD/BRL5.16-0.2400%USD/RUB84.590.7100%USD/NGN1,345.44-0.3200%USD/EGP50.10-1.0300%USD/KES129.370.7200%USD/BDT123.262.1600%USD/LKR328.082.0300%USD/IDR17,690.00-0.6600%USD/THB32.75-0.3300%USD/MYR4.02-0.5700%USD/PHP61.630.0300%USD/VND26,109.00-0.2700%USD/ILS2.97-0.1600%USD/SAR3.753.0700%USD/AED3.670.0300%USD/QAR3.64-0.0400%USD/KWD0.31-0.3200%USD/BHD0.380.0300%USD/OMR0.390.4700%
Wednesday, 26 August 2026
GuruAlpha
Behind the Spotlight: Zaviyar Naumaan’s Hidden Childhood Health Battle Revealed
World

Behind the Spotlight: Zaviyar Naumaan’s Hidden Childhood Health Battle Revealed

Veteran actor Naumaan Masood reveals how Naumaan Ijaz's son Zaviyar survived a life-threatening childhood illness long before achieving stardom.

GA

GuruAlpha News Desk

GuruAlpha News Desk

4 min read
ShareXFacebookWhatsApp

Veteran Pakistani actor Naumaan Masood recently revealed that Zaviyar Naumaan Ijaz, son of legendary actor Naumaan Ijaz, battled a severe, life-threatening illness during early childhood. Long before establishing himself as a rising star on television, Zaviyar faced a critical medical emergency that pushed his family into an intensely fragile emotional crisis.

The Untold Medical Emergency Behind Showbiz Royalty

Behind the glitz of red carpets and television screens lies a vulnerable human reality that seldom reaches public view. During a recent broadcast appearance, actor Naumaan Masood reflected on his decades-long friendship with Naumaan Ijaz, bringing to light an agonizing episode from Zaviyar's toddler years. The illness struck suddenly, causing Zaviyar’s condition to deteriorate rapidly within hours, alarming doctors and placing the family in immediate distress.

Masood recounted how the intense panic gripped the household as medical staff rushed to stabilize the young child. At that time, Naumaan Ijaz stood at the peak of his early career, managing demanding shooting schedules while confronting the nightmare every parent dreads. Masood described visiting the hospital during those tense hours, watching one of Pakistan's most revered actors completely overwhelmed by raw fear for his son's survival. The medical team managed to pull Zaviyar back from the brink through aggressive intervention and round-the-clock monitoring.

This revelatory moment highlights the stark contrast between public persona and private anguish. While audiences saw a composed, dominant performer on their screens, off-camera Naumaan Ijaz was navigating hospital corridors, grappling with the real possibility of losing his eldest child.

From Fragile Childhood to Prime-Time Television

Zaviyar Naumaan's eventual recovery laid the foundation for a life story defined by resilience. Today, viewers recognize Zaviyar as a burgeoning leading man in modern Pakistani dramas, having starred in popular serials such as Sang-e-Mah, Mujhe Pyaar Hua Tha, and Tere Aane Se. However, knowing his childhood health struggle adds a profound layer to his journey into the public eye.

Entering the entertainment industry carries immense pressure, particularly for children of iconic figures. Zaviyar faced persistent scrutiny regarding nepotism and artistic merit when he made his acting debut. Yet, the physical endurance required for marathon shooting schedules—often lasting 14 to 16 hours under harsh lighting—stands as a quiet testament to his complete physical recovery from early trauma.

Colleagues on contemporary sets describe Zaviyar as disciplined and emotionally grounded. The early trial experienced by his family instilled a deep sense of gratitude and humility that continues to shape his professional demeanor today.

Celebrity Vulnerability and the Reality of Pediatric Care

Childhood health crises do not discriminate based on fame or wealth. Rapid pediatric decline remains a critical concern across Pakistan, where conditions like severe dehydration, respiratory distress, and high-grade febrile convulsions can escalate into life-threatening emergencies within short windows. High-profile accounts of such ordeals dismantle the illusion that prominent families live untouched by mortal terror.

When public figures open up about historical family trauma, it resonates deeply with thousands of parents who have sat in pediatric intensive care waiting rooms. Naumaan Masood's disclosure serves as a poignant reminder of human frailty. It illustrates that long before awards, ratings, and red-carpet applause, the primary victory for Naumaan Ijaz's family was simply bringing their young boy safely home from the hospital.

Zaviyar’s path from an intensive care bed to prime-time television screens underscores the power of modern medical intervention combined with relentless parental devotion. As his career trajectory continues upward, this newly disclosed chapter offers fans a meaningful glimpse into the personal fortitude that built the family today.

Frequently Asked Questions

What childhood illness did Zaviyar Naumaan suffer from?

Senior actor Naumaan Masood revealed that Zaviyar experienced a severe, rapidly escalating childhood medical emergency that deteriorated his health and placed his life in critical condition before doctors successfully treated him.

Who revealed the news about Zaviyar Naumaan's childhood illness?

Veteran actor Naumaan Masood shared the story during a broadcast interview, recounting his firsthand memories of supporting long-time friend Naumaan Ijaz during the hospital crisis.

Which popular television dramas has Zaviyar Naumaan starred in?

Zaviyar Naumaan has established his acting career with lead roles in hit Pakistani drama serials including Sang-e-Mah, Mujhe Pyaar Hua Tha, and Tere Aane Se.

Source:express.pk
Share this story
ShareXFacebookWhatsApp
GA

GuruAlpha News Desk

The GuruAlpha News team delivers accurate, timely coverage of breaking news, markets, technology, and lifestyle — in English and Urdu.

NewsBreaking

Related Stories

All World

More Stories

Home

What is GuruAlpha?

GuruAlpha is a comprehensive digital platform offering live financial markets, free calculators, online tools, Islamic content, SIM packages, sports updates and celebrity profiles for Pakistan, Gulf countries and worldwide audiences.

Is GuruAlpha free to use?

Yes, GuruAlpha is completely free. All calculators, tools, market data, prayer times, Islamic resources and content are available without any subscription or sign-up.

Does GuruAlpha provide live market data?

Yes, GuruAlpha provides live market data including USD/PKR exchange rates, gold prices, cryptocurrency prices, stock market indices and commodity prices sourced from reliable financial data providers.

What calculators are available on GuruAlpha?

GuruAlpha offers over 1,200 calculators including Pakistan income tax, salary tax, PTA mobile tax, electricity bill, gold price, currency converter, Zakat calculator, property tax and many more.

Does GuruAlpha have Islamic prayer times?

Yes, GuruAlpha provides accurate prayer times for over 100 cities worldwide including Fajr, Dhuhr, Asr, Maghrib and Isha times. We also offer Qibla direction, Islamic calendar and Zakat calculator.